NIO Stock Falls After Q1 Earnings – Here’s Why
NIO Inc (NYSE: NIO) reported first-quarter FY23 sales growth of 7.7% year-on-year to RMB10.7 billion ($1.56 billion), missing the
Verisign Reports Internet Has 354M Domain Name Registrations At The End Of Q1 2023, Up 3.5M, Or 1% YoY
VeriSign, Inc. (NASDAQ:VRSN), a global provider of domain name registry services and internet infrastructure, today announced that the first quarter of 2023 closed with 354.0 million domain name registrations
Braze Sees Q2 EPS $(0.13)-$(0.14) Vs $(0.16) Est.; Revenue $108M-109M Vs $107.18M Est.; FY24 EPS $(0.51)-$(0.55) Vs $(0.55) Est. Revenue $442.5M-$446.5M Vs $436.43M Est.
Financial Outlook
Braze is initiating guidance for the fiscal second quarter ending July 31, 2023, and updating guidance for the fiscal year ending January 31,
Planet Labs PBC Sees Q2 Revenue $53M-$55M Vs $60.17M Est.; FY24 Revenue $225M-$235M Vs $257.07M Est.
Financial Outlook
For the second quarter of fiscal year 2024, ending July 31, 2023, Planet expects revenue to be in the range of approximately $53 million to $55 million, representing
Why DocuSign Stock Is Surging After Hours
DocuSign Inc (NASDAQ: DOCU) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected
The Duckhorn Portfolio Raises FY23 Revenue Guidance To $400M-$404M Vs $402.56M Est.; EPS $0.64-$0.66 Vs $0.64 Est.
Fiscal 2023 Guidance
The Company is upwardly revising net sales, adjusted EBITDA, and adjusted EPS guidance previously provided for Fiscal 2023.
The Company's revised guidance ranges are
Vail Resorts, Inc. Sees Net Income For FY23 $251M-$283M Vs Est.;
Updated Outlook
Net income attributable to Vail Resorts, Inc. is expected to be between $251 million and $283 million for fiscal 2023.
Resort Reported EBITDA is expected to be
AngioDynamics Announces Sale Of Dialysis Product Portfolio And BioSentry Product To Merit Medical Systems For $100M; Announces Preliminary FY23 Net Sales In The Range Of $338M-$339M Vs $338.83M Est.
Announces preliminary Fiscal Year 2023 net sales in the range of $338 million to $339 million
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on
Faster Than Expected Progress – Carvana Confident About Its Plan To Drive Profitability
Carvana Co (NYSE: CVNA) said it expects to
Why Toro Shares Are Sliding Today
The Toro Co (NYSE: TTC) reported a Q2 FY23 sales growth of 7% Y/Y to $1.34 billion, missing